Skip to main content

Table 3 Major Complications. (Definition: admission, organ failure or mortality)

From: Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study

 

Group 1, Aggressive treatment

(N = 59)

Group 2, Supportive treatment

(N = 23)

P - Value

Infection

 CMV disease

10

3

0.663

 Bacterial pneumonia

9

2

0.433

 PCP pneumonia

4

0

0.650

 Cryptococcal pneumonia

1

0

0.505

 Penicillium marneffei pneumonia

1

0

0.505

 Infectious diarrhea

6

1

0.372

 Urinary tract infection

8

0

0.212

 Epididymitis

1

0

0.505

 Cellulitis

3

0

0.889

 Abscess, retroperitoneal

1

0

0.505

 Abscess, lung

1

0

0.505

 Peritonitis

1

0

0.505

 Fungemia

1

0

0.505

Leukopenia

8

1

0.231

Mortality¶

6

3

0.708

Total number of AEs

54

7

 

Mean number AEs per patient

1.0 [0.0–2.2]

0.0 [0.0–0.7]

<  0.001

  1. ¶All the mortality cases in the aggressive treatment group died of sepsis, whereas two of those in no treatment group died of sepsis, another case died of hemorrhagic shock. PCP Pneumocystis carinii pneumonia. AE adverse events